2014China Foreign Medical TreatmentRequires access

Analysis of the Curative Effect of Clindamycin in the Treatment of Mycoplasma Pneumonia in Children

HE Tiefe

Open publisher page 0 citations

Abstract

Objective To investigate and study the clinical efficacy of clindamycin in the treatment of mycoplasma pneumonia in children. Methods The clinical data of 88 children with mycoplasma pneumonia admitted in our hospital from January 2009 to January 2013 were selected as the subjects. And the children were randomly divided into the observation group and the control group with 44 children in each. The control group was treated by azithromycin, and the observation group was treated by clindamycin on the basis of azithromycin. The efficacies of the two groups of children were counted and compared. Results The efficacies of the groups showed that the total effective rate and markedly effective rate of the observation group was 95.5%, 61.3%, respectively, higher than 81.8%, 36.3% of the control group, respectively, the differences were statistically significant(P0.05). The incidence of adverse reactions of the observation group was 6.8%, and that of the control group was 9.1%, the difference was not statistically significant(P0.05). Conclusion Clindamycin is quite effective in the treatment of children with mycoplasma pneumonia. The effect of clindamycin combined with azithromycin is much better than that of azithromycin, and it is worthy of promotion and application in clinical practice.

About this research paper

What this paper is about

Objective To investigate and study the clinical efficacy of clindamycin in the treatment of mycoplasma pneumonia in children. Methods The clinical data of 88 children with mycoplasma pneumonia admitted in our hospital from January 2009 to January 2013 were selected as the subjects. And the children were randomly divided into the observation group and the control group with 44 children in each. The control group was treated by azithromycin, and the observation group was treated by clindamycin on the basis of azithromycin. The efficacies of the two groups of children were counted and compared. Results The efficacies of the groups showed that the total effective rate and markedly effective rate of the observation group was 95.5%, 61.3%, respectively, higher than 81.8%, 36.3% of the control group, respectively, the differences were statistically significant(P0.05). The incidence of adverse reactions of the observation group was 6.8%, and that of the control group was 9.1%, the difference was not statistically significant(P0.05). Conclusion Clindamycin is quite effective in the treatment of children with mycoplasma pneumonia. The effect of clindamycin combined with azithromycin is much better than that of azithromycin, and it is worthy of promotion and application in clinical practice.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate and study the clinical efficacy of clindamycin in the treatment of mycoplasma pneumonia in children. Methods The clinical data of 88 children with mycoplasma pneumonia admitted in our hospital from January 2009 to January 2013 were selected as the subjects. And the children were randomly divided into the observation group and the control group with 44 children in each. The control group was treated by azithromycin, and the observation group was treated by clindamycin on the basis of azithromycin. The efficacies of the two groups of children were counted and compared. Results The efficacies of the groups showed that the total effective rate and markedly effective rate of the observation group was 95.5%, 61.3%, respectively, higher than 81.8%, 36.3% of the control group, respectively, the differences were statistically significant(P0.05). The incidence of adverse reactions of the observation group was 6.8%, and that of the control group was 9.1%, the difference was not statistically significant(P0.05). Conclusion Clindamycin is quite effective in the treatment of children with mycoplasma pneumonia. The effect of clindamycin combined with azithromycin is much better than that of azithromycin, and it is worthy of promotion and application in clinical practice.

Key concepts: Azithromycin, Medicine, Clindamycin, Mycoplasma pneumonia, Mycoplasma, Incidence (geometry), Internal medicine, Pneumonia

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis of the Curative Effect of Clindamycin in the Treatment of Mycoplasma Pneumonia in Children — Research Paper | ScholarLens